- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Balchem Corporation(BCPC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BCPC
11/13/2026: BCPC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Balchem Corporation is a specialty performance ingredient and chemical manufacturer operating across human nutrition, animal health, and industrial sterilization markets. The company's primary strengths lie in its proprietary microencapsulation technologies, sticky customer relationships, and consistently high operating margins. A key growth catalyst is the expanding global demand for functional foods, dietary supplements, and advanced nutritional additives. However, risks include elevated valuation multiples, sensitivity to agricultural cycles, and competition from larger chemical enterprises. The stock suits long-term growth and dividend-growth investors seeking quality defensive exposure, with monitoring required on valuation levels and raw material cost trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Balchem delivers steady mid-single-digit organic growth supplemented by targeted M&A rather than explosive hyper-growth. |
| Momentum investor | Strong fit while signal remains positive | Momentum appeal depends on positive technical breakout signals and near-term earnings beats. |
| Value investor | Mixed fit | Valuation multiples often command a premium due to high quality and consistent margins, limiting deep-value appeal. |
| Dividend investor | Strong fit | The company has an extensive history of consecutive annual dividend increases backed by pristine cash flows. |
| Low-risk investor | Strong fit | Low leverage, robust balance sheet health, and defensive end-markets provide a relatively lower-risk equity profile. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock experiences standard equity market fluctuations but generally exhibits lower beta than cyclical chemical peers. |
| Valuation risk | Medium / high | Trading at elevated price-to-earnings multiples leaves little room for operational disappointments. |
| Competition risk (Specialty ingredient and flavor competition) | Medium | Competition from larger global ingredient giants can pressure pricing power in core segments. |
| Business quality | Strong | Proprietary technology and sticky customer relationships underpin high franchise quality. |
| Dividend income | Low | The dividend yield is modest, making it more suitable for dividend growth than immediate income generation. |
| Execution risk | Low / none | Management has a long history of successfully integrating bolt-on acquisitions and executing operational plans. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.52B USD | Price to earnings Ratio 32.67 | 1Y Target Price 213.5 |
Price to earnings Ratio 32.67 | 1Y Target Price 213.5 | ||
Volume (30-day avg) 304.1K shares | Beta 0.85 | 52 Weeks Range 146.28 - 186.15 | Updated Date 11/15/2026 |
52 Weeks Range 146.28 - 186.15 | Updated Date 11/15/2026 | ||
Dividends yield (FY) 0.56% | Basic EPS (TTM) 5.3 |
Sector & Industry Intelligence
Sector
Basic Materials
Defensive- Sentiment
- Bearish
- Momentum
- Momentum Steady
- BUY participation
- 23.1%
- Active BUY / eligible
- 9 / 39
- 30-Day BUY Count Change
- +2
- Market state
- Bearish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Specialty Chemicals
- BUY participation
- 57.1%
- Active BUY / eligible
- 4 / 7
- 30-Day BUY Count Change
- +1
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Flat / Range-Bound
The stock price has been trading within a narrow range with minimal directional movement.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -23.09% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Human Nutrition and Health | Supplies choline, minerals, vitamin K2, and customized powder/liquid ingredient systems for foods and supplements. | This is the company's largest and fastest-growing profit engine driven by health-conscious consumer trends. |
| Animal Nutrition and Health | Manufactures rumen-protected encapsulated nutrients to maximize livestock health and feeding efficiency. | Revenue tracks farm-level economic returns and dairy market cycles. |
| Specialty Products | Produces high-purity ethylene oxide gas used for medical device sterilization and agricultural fumigants. | A smaller segment that delivers exceptionally high profit margins due to essential non-discretionary demand. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-23 | When Before Market | Estimate 1.54 | Actual 1.57 |
Profitability
Profit Margin 15.41% | Operating Margin (TTM) 20.7% |
Management Effectiveness
Return on Assets (TTM) 8.53% | Return on Equity (TTM) 13.02% |
Valuation
Trailing PE 32.67 | Forward PE 29.59 | Enterprise Value 5.60B | Price to Sales(TTM) 4.98 |
Enterprise Value 5.60B | Price to Sales(TTM) 4.98 | ||
Enterprise Value to Revenue 5.05 | Enterprise Value to EBITDA 20.19 | Shares Outstanding 31.88M | Shares Floating 31.59M |
Shares Outstanding 31.88M | Shares Floating 31.59M | ||
Percent Insiders 0.59 | Percent Institutions 93.15 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

